$IBIO Okay Im going to assume its okay to compare Medicago's VLP and Adjuvant to iBio's. I am not a Bio major but the technology must be really similar if not the same. On may 14th Medicago, a biopharmaceutical company headquartered in Quebec City, announced today that its vaccine candidate for COVID-19 induced a positive antibody response only 10 days after a single dose in mice. “These positive results are pivotal to initiate a clinical study in healthy volunteers. Once results from a second ‘boost’ dose are available" "In early March, the company produced a Virus-Like Particle (VLP) of the coronavirus just 20 days after obtaining the SARS-CoV-2 gene and quickly initiated pre-clinical testing. The company expects to initiate Phase I clinical trials this summer. Following this trial, it is anticipated that the Phase 2 study will begin prior to the end of 2020." If we assume iBio and Medicago are on a similar pace, this gives an insight to the progress of iBIo.
  • 4
  • 2
4 Likes